Pozelimab + cemdisiran

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Pozelimab + cemdisiran
Treatment and conditionWhere it standsTrials
Pozelimab + cemdisiran for hemoglobinuria, paroxysmalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1